Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma

This publication has 19 references indexed in Scilit:

• The pharmacological basis of anti-IgE therapy
  Nature Biotechnology, 2000
• Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
  New England Journal of Medicine, 1999
• Difficult asthma
  European Respiratory Journal, 1998
• Therapeutic potential of anti-IgE antibodies
  Current Opinion in Immunology, 1997
• Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★
  Journal of Allergy and Clinical Immunology, 1997
• The inflammatory basis of asthma and its implications for drug treatment
  Clinical and Experimental Allergy, 1996
• Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgE
  Biochemistry, 1995
• Anti-lgE Monoclonal Antibodies that Inhibit Allergen-Specific Histamine Release
  International Archives of Allergy and Immunology, 1995
• Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to Allergens
  New England Journal of Medicine, 1989
• Standardization and stability of immunoglobulin E (IgE)
  Journal of Allergy and Clinical Immunology, 1972